FDA_TrackerJim said:Nothing dramatic to report, which is the report.
Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.
Ask again with the specifics and you will get a better answer than this one.
FDA_TrackerJim said:Nothing dramatic to report, which is the report.
No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.
FDA_TrackerJim said:Nothing dramatic to report, which is the report.
Thank you for spelling out the reasoning rather than just the conclusion.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsAdding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.
Dr.CardioMD said:The useful move here is to separate what is established from what is widely repeated.
Same experience, arrived at from the opposite direction. The detail I would add is minor and it is already implied above.